Geron (GERN) 10-K2009 FY Annual report

Filed: 26 Feb 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: addendum, advisor, ahead, aliquoted, alliance, Alzheimer, amidate, answer, articular, attrition, authoritative, awaiting, background, Birmingham, Blackburn, bore, CAFC, calcium, Canada, cardiomyocyte, cardiotoxicity, Carol, cavity, Chair, channel, ChanTest, Circuit, clonogenic, colony, Conference, confidence, confined, confirmatory, contemplated, context, contingent, CR, criterion, cytochrome, defect, Dentistry, depleted, display, Doctorate, DTH, economy, electrophysiological, ELISPOT, Elizabeth, embrace, encourage, endoderm, enriched, epithelial, expansion, Exponent, fall, floating, Fox, frequency, GE, GEHC, Genentech, glioma, greatly, Greider, harvest, headache, Healthcare, heard, hepatotoxicity, hERG, highlight, Hospital, host, hypersensitivity, Idiopathic, imetelstat, immature, inconsistent, India, innovation, installment, ion, Italy, Jack, Japan, Journal, Kelsey, Korea, lecturer, legend, London, master, Median, messenger, migrate, Milan, mild, mind, moderate, modest, mononuclear, National, neuroblastoma, Nobel, noncommercial, notified, Novocell, Obama, occasional, occurrence, oil, Ontario, overview, package, pediatric, peripheral, persist, Pharm, Pharmacia, physiological, physiology, play, prevailing, Prize, proper, purpura, put, qPCR, rash, regrowth, remission, rescinded, rest, restarted, retired, Royal, RPS, sequentially, shortly, signal, simultaneously, sodium, South, span, St, Steering, Stephen, sterility, Strict, stroke, SUGEN, Summit, Szostak, Terry, thawing, thrombocythemia, thrombocytopenic, tool, transfected, transfection, Twenty, unchanged, uncommon, underway, unemployment, Vancouver, vessel, viral, visiting, Western, widespread

Removed: accelerate, allocate, andin, andsafety, anex, announced, APB, APIC, approximate, arm, arose, assigning, augment, begun, belief, Bioscience, bothin, bridge, build, Bulletin, Bush, calculating, Calvin, Campbell, Canadian, Chairmen, challenge, characterize, clarify, clear, concurrence, Council, cumulatively, discrete, diversify, doubling, drawdown, durability, durable, EITF, elimination, Emerging, enforcingpatent, enroll, enrolled, equaled, evidenced, execute, faced, FAS, FASB, FIN, footnote, forin, forma, funded, geographic, Gerontology, Harley, headcount, heal, hepatocyte, ifin, immunomodulatory, immunotherapeutic, indexed, injecting, instructed, interpretation, invalidation, investigator, leader, leg, Leigh, managing, McMaster, measuring, metabolize, metastatic, negotiate, newly, orlack, outlined, peak, pool, prescribe, presently, pro, Professor, promoter, PSA, recognizing, SAB, scheme, secretion, Sensitivity, separately, serum, simplified, standardized, strong, suggestive, surrogate, Sussex, Task, theex, theJournal, thereunder, threshold, toprevent, transplanting, traveled, treatmentsover, Treaty, undue, validity, Waterloo, Whinston, Worcester, xenotransplantation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

GERN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Geron Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that:

	(i)		the accompanying annual report on Form 10-K of the Company for the year ended December 31, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

	(ii)		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 26, 2010	/S/ DAVID L. GREENWOOD
	DAVID L. GREENWOOD
	Executive Vice President
	Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Geron Corporation and will be retained by Geron Corporation and furnished to the Securities and Exchange Commission or its staff upon request.